Sunday, October 12, 2025

The Allure of the Large AI Drug Discovery Market.

China-origin assets accounted for an even larger share of big pharma licensing in Q1 2026

https://www.jpmorgan.com/content/dam/jpmorgan/documents/cb/insights/outlook/jpm-biopharma-deck-q1-2026.pdf